Related Experiment Video

Updated: Aug 5, 2026

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
10:38

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

Published on: July 17, 2014

The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA

A Rainczuk1, P M Smooker, L Kedzierski

  • 1Department of Biochemistry and Molecular Biology, The Cooperative Research Centre for Vaccine Technology, Clayton 3800, Australia. adam.rainczuk@med.monash.edu.au

Vaccine
|June 12, 2003
PubMed

Insights

Enhancing malaria DNA vaccines is crucial for practical application. DNA vaccine vector type and delivery route significantly impact survival against blood-stage malaria, with gene-gun vaccination showing promise.

Area of Science:

  • Immunology
  • Vaccinology
  • Parasitology

Background:

  • Developing effective vaccines against blood-stage malaria is critical for disease control.
  • Enhancing the immunogenicity of DNA vaccines is key to their practical application.
  • Merozoite surface protein 4/5 (MSP4/5) is a target for malaria vaccine development.

Purpose of the Study:

  • To evaluate the efficacy of different DNA vaccine vector types encoding MSP4/5 against Plasmodium chabaudi adami DS challenge.
  • To investigate the impact of various immunization routes (gene-gun, IM injection) and boosting strategies on vaccine-induced immune responses and survival.

Main Methods:

  • MSP4/5 gene was inserted into three distinct DNA vaccine vectors: VR1020 (secretory), MCP-3 (chemoattractant), and CTLA4 (lymph node targeting).
  • Mice were immunized via intradermal gene-gun, intramuscular injection, or boosted with recombinant MSP4/5 protein.
  • Humoral immune responses (antibody isotypes, avidity) and survival rates following lethal blood-stage malaria challenge were assessed.

Main Results:

  • Antibody responses were predominantly IgG1 and IgE, with low avidity antibodies in DNA-primed groups.
  • Boosting with recombinant MSP4/5 did not improve survival in mice primed with MCP-3 or CTLA4 vectors.
  • Gene-gun vaccination with VR1020/MSP4/5 followed by protein boosting, or gene-gun delivery of MCP-3/MSP4/5 alone, enhanced survival compared to controls.

Conclusions:

  • The effectiveness of MSP4/5 DNA vaccination against lethal blood-stage malaria is highly dependent on the chosen vaccine vector and delivery method.
  • Gene-gun delivery appears to be a superior route for enhancing survival in this malaria model.
  • Further research into optimized DNA vaccine vectors and delivery systems is warranted for malaria control.

More Related Videos

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

Detection of Plasmodium Sporozoites in Anopheles Mosquitoes using an Enzyme-linked Immunosorbent Assay07:04

Detection of Plasmodium Sporozoites in Anopheles Mosquitoes using an Enzyme-linked Immunosorbent Assay

Published on: September 30, 2021

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...